Methadone

Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort

Citation
Heikkinen, M., Taipale, H., Tanskanen, A., Mittendorfer‐Rutz, E., Lähteenvuo, M., & Tiihonen, J. (2022). Real‐world effectiveness of pharmacological treatments of opioid use disorder in a national cohort. Addiction.
Publication Date
Abstract
Aim

To investigate the real-world effectiveness of pharmacological treatments (buprenorphine, methadone) of opioid use disorder (OUD).

Design

A nation-wide, register-based cohort study.

Setting

Sweden.

Structural violence and the need for compassionate use of methadone in Mexico

Citation
Romero-Mendoza, M., Peláez-Ballestas, I., Almanza-Avendaño, A.M. et al. Structural violence and the need for compassionate use of methadone in Mexico. BMC Public Health 22, 606 (2022). https://doi.org/10.1186/s12889-022-12955-x
Publication Date

Abstract

Background

Epidemiological data from Mexico have documented an increase in heroin use in the last decade. However, there is no comprehensive care strategy for heroin users, especially those who have been accused of a crime.

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

Citation
Biondi, B.E., Vander Wyk, B., Schlossberg, E.F. et al. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community. Addict Sci Clin Pract 17, 15 (2022). https://doi.org/10.1186/s13722-022-00299-1
Publication Date

Abstract

Background

Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death. Few persons who initiate MOUD are retained on treatment, thus it is critical to identify factors associated with retention.

The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya

Citation
Ngarachu, E.W., Kiburi, S.K., Owiti, F.R. et al. The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya. Subst Abuse Treat Prev Policy 17, 12 (2022). https://doi.org/10.1186/s13011-022-00437-7
Publication Date

Cannabis is the most widely used illegal substance in the world, with a global prevalence of 4% among people aged 15 to 64 years and a recent trend of growing use.

The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya

Citation
Ngarachu, E.W., Kiburi, S.K., Owiti, F.R. et al. The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya. Subst Abuse Treat Prev Policy 17, 12 (2022). https://doi.org/10.1186/s13011-022-00437-7
Publication Date

Abstract

Background

Cannabis use during methadone treatment may negatively impact treatment outcomes. The aim of this study was to determine the prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya.

Methadone maintenance treatment

Published by
Ministerio de Salud y Protección Social de Colombia
Publication Date

Document of the Ministry of Health and Social Protection of Colombia that presents baseline of the maintenance programs with methadone in the country and the profile of the population served and the general characteristics of the treatment, as well as recommendations in public health for the strengthening of these programs.

Gender disparities in opioid treatment progress in methadone versus counselling

Citation
Guerrero, E., Amaro, H., Kong, Y. et al. Gender disparities in opioid treatment progress in methadone versus counseling. Subst Abuse Treat Prev Policy 16, 52 (2021). https://doi.org/10.1186/s13011-021-00389-4
Publication Date

The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies.

Plausibility of patient-centred care in high-intensity methadone treatment: Reflections of providers and patients

Citation
Marshall, K., Maina, G. & Sherstobitoff, J. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients. Addict Sci Clin Pract 16, 42 (2021). https://doi.org/10.1186/s13722-021-00251-9
Publication Date

Abstract

Background: Patients with opioid use disorder (OUD) often have complex health care needs. Methadone is one of the medications for opioid use disorder (MOUD) used in the management of OUDs. Highly restrictive methadone treatment—which requires patient compliance with many rules of care—often results in low retention, especially if there is inadequate support from healthcare providers (HCPs).

Take-Home Dosing Experiences among Persons Receiving Methadone Maintenance Treatment during COVID-19

Citation
Figgatt, M. C., Salazar, Z., Day, E., Vincent, L., & Dasgupta, N. (2021). Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. Journal of Substance Abuse Treatment, 123, 108276.

Abstract

Purpose

Methadone maintenance treatment is a life-saving treatment for people with opioid use disorders (OUD). The coronavirus pandemic (COVID-19) has introduced many concerns surrounding access to opioid treatment. In March 2020, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued guidance allowing for the expansion of take-home methadone doses.

Cannabis Use during Methadone Maintenance Treatment for Opioid Use Disorder: A Systematic Review and Meta-Analysis

Citation
CMAJ Open 2019. DOI:10.9778/cmajo.20190026
Publication Date

Abstract

Background: Rates of cannabis use among patients receiving methadone maintenance therapy are high, and cannabis use may be associated with outcomes of methadone maintenance therapy. We examined the effect of cannabis use on opioid use in patients receiving methadone maintenance therapy to test the hypothesis that cannabis use is associated with a reduction in opioid use.